Board Type
Posts Today
Posts Last 30 Days

Sangamo Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on translating ground-breaking science into genomic therapies that transform patients' lives using platform technologies in genome editing, gene therapy, gene regulation, and cell therapy. The company?s proprietary zinc finger DNA-binding protein (ZFP) technology enables specific genome editing and gene regulation. The ZFPs could be engineered to make ZFP nucleases (ZFNs), proteins that could be used to specifically modify DNA sequences by adding or knocking out specific genes; and ZFP transcription factors (ZFP TFs), proteins that can be used to turn genes on or off. Its therapeutic products include SB-728-T, a ZFN-mediated autologous T-cell product for human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS), which is in Phase II and Phase I clinical trials; and SB-728-HSPC that is in Phase I/II clinical trials for HIV/AIDS. The company also engages in Phase I/II studies of in vivo genome editing applications of ZFP Therapeutics for hemophilia B, Hemophilia A, and Mucopolysaccharidosis I (MPS) and MPS II, which are lysosomal storage disorder (LSD); proprietary preclinical programs in other LSDs; and research stage programs in certain central nervous system disorders and cancer immunotherapies. It has collaborative partnerships with Biogen Inc. to develop therapeutic genome editing products in hemoglobinopathies; and with Shire International GmbH to develop the preclinical development program in Huntington?s disease, as well as license agreement with Sigma-Aldrich Corporation to develop ZFP-based laboratory research reagents and Dow AgroSciences, LLC to modify the genomes or alter protein expression of plant cells, plants, or plant cell cultures. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. Sangamo Therapeutics, Inc. was founded in 1995 and is headquartered in Richmond, California.

PlusOneCoin Top Posts Free PlusOneCoin
No plusone'd posts yet. Be the first!
Post Subject
#415 MWM 01/09/2021 04:08:45 PM
#414 This is an excellent read on SGMO MWM 01/05/2021 03:41:08 AM
#413 Good call but hard to say what it MWM 12/31/2020 03:44:05 PM
#412 Looks like it's doing exactly what I predicted. The Canes 12/31/2020 03:25:30 PM
#411 loved how everyone was hatting this company at Fress 12/29/2020 08:42:09 AM
#410 SGMO owns patents on CRSPR technology used by hitekmastr 12/28/2020 01:54:20 PM
#409 $SGMO I have a lot of Calls! Outpreforming MWM 12/28/2020 12:32:18 PM
#408 SGMO moving here now Rockurstocks 12/28/2020 11:42:38 AM
#407 I think it can be $25 in the MWM 12/27/2020 11:58:18 AM
#406 HC Wainright tags SGMO at 25.00. My guess Seeker213 12/26/2020 06:53:52 PM
#405 No, I think it plays catchup to the MWM 12/24/2020 10:51:21 AM
#404 I think later next year if we see The Canes 12/24/2020 10:35:46 AM
#403 $SGMO I have a good feeling about this one. MWM 12/24/2020 06:14:27 AM
#402 SGMO Sangamo has prioritized intellectual property as an MWM 12/23/2020 08:32:57 PM
#401 Got some Jan $20 calls $SGMO$ Rockurstocks 12/23/2020 01:22:05 PM
#400 $SGMO I reloaded on the dip today, looks MWM 12/23/2020 12:57:25 PM
#399 A double from here looks very doable comparing MWM 12/23/2020 07:02:53 AM
#398 SGMO moving toward stratosphere, finally...50-100. hitekmastr 12/23/2020 06:50:58 AM
#397 What a beast!!! Fress 12/22/2020 03:05:09 PM
#396 $SGMO added some calls, I think Sangamo is MWM 12/22/2020 12:24:19 PM
#395 $SGMO staying, forming a nice chart towards 25 Seeker213 12/22/2020 08:59:44 AM
#394 $SGMO ready for next leg up 20-25. Going long Seeker213 12/22/2020 06:30:19 AM
#393 $20.00 soon hasn't run like Beam or Edit Fress 12/22/2020 05:39:31 AM
#392 Strong close yesterday. Someone acquiring 100k, 200k towards close Seeker213 12/19/2020 06:40:54 AM
#391 Seeker213 12/12/2020 08:42:44 AM
#390 What happened to the hiv drug they had akamaii 12/12/2020 08:39:08 AM
#389 SGMO Huge pipeline too cheap here. Another CSPR Seeker213 12/11/2020 02:11:30 PM
#388 HEARING $SGMO CEO " just said MWM 12/11/2020 12:26:44 PM
#387 Sangamo participates in a conference call with Truist MWM 12/11/2020 06:04:00 AM
#386 2022 $12 Calls looking good. hitekmastr 12/11/2020 12:23:33 AM
#385 Thank you tikotiko 12/10/2020 08:15:42 PM
#384 I loaded next weeks. The $15’s I bought MWM 12/10/2020 07:10:40 PM
#383 Nice! There are lotto calls which are my MWM 12/10/2020 07:09:17 PM
#382 May I ask you what time period you tikotiko 12/10/2020 04:46:13 PM
#381 LOL Ain't that the Truth my Friend! That's DTGoody 12/10/2020 04:35:49 PM
#380 God I hope it is a buyout, I MWM 12/10/2020 04:11:09 PM
#379 DT it got to $13 lol! Just took MWM 12/10/2020 04:09:52 PM
#378 $SGMO MWM 12/10/2020 04:08:15 PM
#377 I bought an ass load more of Calls MWM 12/10/2020 03:56:53 PM
#376 Finally is right. I am glad I tikotiko 12/10/2020 03:56:37 PM
#375 $SGMO something Major must be coming, Breakout above $14! MWM 12/10/2020 03:43:01 PM
#374 SGMO Finally! MWM 12/10/2020 03:39:05 PM
#373 I agree! I have options that are going DTGoody 07/16/2020 10:15:45 AM
#372 Took at starter almost a billion in cash Fress 07/16/2020 04:25:42 AM
#371 Come on SGMO Move up to around $13 DTGoody 07/01/2020 07:48:18 PM
#370 I wonder why SGMO has gone down so DTGoody 06/19/2020 04:47:04 PM
#369 Updated the Ibox MWM 06/11/2020 03:15:32 PM
#368 MWM 06/11/2020 03:01:33 PM
#367 $SGMO Call Volume pic MWM 06/11/2020 02:35:39 PM
#366 PFE is a partner with SGMO in Hemo. MWM 06/11/2020 02:33:44 PM
Post Subject